Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Frederick J. Angulo is active.

Publication


Featured researches published by Frederick J. Angulo.


Emerging Infectious Diseases | 2011

FOODBORNE ILLNESS ACQUIRED IN THE UNITED STATES-MAJOR PATHOGENS

Elaine Scallan; Robert M. Hoekstra; Frederick J. Angulo; Robert V. Tauxe; Marc-Alain Widdowson; Sharon L. Roy; Jeffery L. Jones; Patricia M. Griffin

Each year, 31 pathogens caused 9.4 million episodes of foodborne illness, resulting in 55,961 hospitalizations and 1,351 deaths.


Clinical Infectious Diseases | 2004

FoodNet Estimate of the Burden of Illness Caused by Nontyphoidal Salmonella Infections in the United States

Andrew C. Voetsch; Thomas Van Gilder; Frederick J. Angulo; Monica M. Farley; Sue Shallow; Ruthanne Marcus; Paul R. Cieslak; Valerie Deneen; Robert V. Tauxe

To determine the burden of Salmonella infections in the United States, Foodborne Diseases Active Surveillance Network (FoodNet) investigators conducted population-based active surveillance for culture-confirmed Salmonella infections during 1996-1999 at FoodNet laboratories. In addition, all clinical microbiology FoodNet laboratories were surveyed to determine their practices for isolating Salmonella. Telephone interviews were also conducted among residents of the FoodNet sites to determine the proportion of persons with diarrheal illness who sought medical care and the proportion who submitted stool specimens for bacterial culture. Using our model, we estimated that there were 1.4 million nontyphoidal Salmonella infections in the United States, resulting in 168,000 physician office visits per year during 1996-1999. Including both culture-confirmed infections and those not confirmed by culture, we estimated that Salmonella infections resulted in 15,000 hospitalizations and 400 deaths annually. These estimates indicate that salmonellosis presents a major ongoing burden to public health.


The New England Journal of Medicine | 1998

Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States

Glynn Mk; Bopp C; Dewitt W; Dabney P; Mokhtar M; Frederick J. Angulo

BACKGROUND Strains of salmonella that are resistant to antimicrobial agents have become a worldwide health problem. A distinct strain of Salmonella enterica serotype typhimurium, known as definitive type 104 (DT104), is resistant to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline and has become a major cause of illness in humans and animals in Europe, especially the United Kingdom. METHODS To characterize typhimurium DT104 infections in the United States, we analyzed data collected by local and state health departments and public health laboratories between 1979 and 1996 in national surveys of the antimicrobial-drug resistance of salmonella. Selected typhimurium isolates with the five-drug pattern of resistance were phage typed. RESULTS The prevalence of typhimurium isolates with the five-drug pattern of resistance increased from 0.6 percent in 1979-1980 to 34 percent in 1996. In 1994-1995, such isolates were identified in samples from 36 of the 46 surveillance sites (78 percent). Thirty-nine of 43 typhimurium isolates with the five-drug pattern of resistance identified in 1994-1995 and 1996 were phage type DT104 or a closely related phage type. CONCLUSIONS Multidrug-resistant typhimurium DT104 has become a widespread pathogen in the United States. More prudent use of antimicrobial agents in farm animals and more effective disease prevention on farms are necessary to reduce the dissemination of multidrug-resistant typhimurium DT104 and to slow the emergence of resistance to additional agents in this and other strains of salmonella.


Emerging Infectious Diseases | 2011

Foodborne Illness Acquired in the United States—Unspecified Agents

Elaine Scallan; Patricia M. Griffin; Frederick J. Angulo; Robert V. Tauxe; Robert M. Hoekstra

Each year, unspecified agents caused an estimated 38.4 million episodes of illness, resulting in 71,878 hospitalizations and 1,686 deaths.


Emerging Infectious Diseases | 2013

Attribution of foodborne illnesses, hospitalizations, and deaths to food commodities by using outbreak data, United States, 1998-2008.

John A. Painter; Robert M. Hoekstra; Tracy Ayers; Robert V. Tauxe; Christopher R. Braden; Frederick J. Angulo; Patricia M. Griffin

Each year, >9 million foodborne illnesses are estimated to be caused by major pathogens acquired in the United States. Preventing these illnesses is challenging because resources are limited and linking individual illnesses to a particular food is rarely possible except during an outbreak. We developed a method of attributing illnesses to food commodities that uses data from outbreaks associated with both simple and complex foods. Using data from outbreak-associated illnesses for 1998–2008, we estimated annual US foodborne illnesses, hospitalizations, and deaths attributable to each of 17 food commodities. We attributed 46% of illnesses to produce and found that more deaths were attributed to poultry than to any other commodity. To the extent that these estimates reflect the commodities causing all foodborne illness, they indicate that efforts are particularly needed to prevent contamination of produce and poultry. Methods to incorporate data from other sources are needed to improve attribution estimates for some commodities and agents.


The New England Journal of Medicine | 2000

Ceftriaxone-Resistant Salmonella Infection Acquired by a Child from Cattle

Paul D. Fey; Thomas J. Safranek; Mark E. Rupp; Eileen F. Dunne; Efrain M. Ribot; Peter C. Iwen; Patricia A. Bradford; Frederick J. Angulo; Steven H. Hinrichs

BACKGROUND The emergence of resistance to antimicrobial agents within the salmonellae is a worldwide problem that has been associated with the use of antibiotics in livestock. Resistance to ceftriaxone and the fluoroquinolones, which are used to treat invasive salmonella infections, is rare in the United States. We analyzed the molecular characteristics of a ceftriaxone-resistant strain of Salmonella enterica serotype typhimurium isolated from a 12-year-old boy with fever, abdominal pain, and diarrhea. METHODS We used pulsed-field gel electrophoresis and analysis of plasmids and beta-lactamases to compare the ceftriaxone-resistant S. enterica serotype typhimurium from the child with four isolates of this strain obtained from cattle during a local outbreak of salmonellosis. RESULTS The ceftriaxone-resistant isolate from the child was indistinguishable from one of the isolates from cattle, which was also resistant to ceftriaxone. Both ceftriaxone-resistant isolates were resistant to 13 antimicrobial agents; all but one of the resistance determinants were on a conjugative plasmid of 160 kb that encoded the functional group 1 beta-lactamase CMY-2. Both ceftriaxone-resistant isolates were closely related to the three other salmonella isolates obtained from cattle, all of which were susceptible to ceftriaxone. CONCLUSIONS This study provides additional evidence that antibiotic-resistant strains of salmonella in the United States evolve primarily in livestock. Resistance to ceftriaxone, the drug of choice for invasive salmonella disease, is a public health concern, especially with respect to children, since fluoroquinolones, which can also be used to treat this disease, are not approved for use in children.


Clinical Infectious Diseases | 2007

Fluoroquinolone-Resistant Campylobacter Species and the Withdrawal of Fluoroquinolones from Use in Poultry: A Public Health Success Story

Jennifer M. Nelson; Tom Chiller; John H. Powers; Frederick J. Angulo

Campylobacter species cause 1.4 million infections each year in the United States. Fluoroquinolones (e.g., ciprofloxacin) are commonly used in adults with Campylobacter infection and other infections. Fluoroquinolones (e.g., enrofloxacin) are also used in veterinary medicine. Human infections with fluoroquinolone-resistant Campylobacter species have become increasingly common and are associated with consumption of poultry. These findings, along with other data, prompted the US Food and Drug Administration to propose the withdrawal of fluoroquinolone use in poultry in 2000. A lengthy legal hearing concluded with an order to withdraw enrofloxacin from use in poultry (effective in September 2005). Clinicians are likely to continue to encounter patients with fluoroquinolone-resistant Campylobacter infection and other enteric infection because of the continued circulation of fluoroquinolone-resistant Campylobacter species in poultry flocks and in persons returning from foreign travel who have acquired a fluoroquinolone-resistant enteric infection while abroad. Judicious use of fluoroquinolones and other antimicrobial agents in human and veterinary medicine is essential to preserve the efficacy of these important chemotherapeutic agents.


Emerging Infectious Diseases | 2006

Web-based Surveillance and Global Salmonella Distribution, 2000–2002

Eleni Galanis; Danilo Lo Fo Wong; Mary Evans Patrick; Norma Binsztein; Anna Cieslik; Thongchai Chalermchaikit; Awa Aidara-Kane; Andrea Ellis; Frederick J. Angulo; Henrik Caspar Wegener

Surveillance improves control of Salmonella infections.


Emerging Infectious Diseases | 2009

Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009

Carrie Reed; Frederick J. Angulo; David L. Swerdlow; Marc Lipsitch; Martin I. Meltzer; Daniel B. Jernigan; Lyn Finelli

Through July 2009, a total of 43,677 laboratory-confirmed cases of influenza A pandemic (H1N1) 2009 were reported in the United States, which is likely a substantial underestimate of the true number. Correcting for under-ascertainment using a multiplier model, we estimate that 1.8 million–5.7 million cases occurred, including 9,000–21,000 hospitalizations.


The Journal of Infectious Diseases | 2005

Antimicrobial-Resistant Nontyphoidal Salmonella Is Associated with Excess Bloodstream Infections and Hospitalizations

Jay K. Varma; Kåre Mølbak; Timothy J. Barrett; James L. Beebe; Timothy F. Jones; Therese Rabatsky-Ehr; Kirk E. Smith; Duc J. Vugia; Hwa-Gan H. Chang; Frederick J. Angulo

BACKGROUND Nontyphoidal Salmonella is a leading cause of foodborne illness. Few studies have explored the health consequences of antimicrobial-resistant Salmonella. METHODS The National Antimicrobial Resistance Monitoring System (NARMS) performs susceptibility testing on nontyphoidal Salmonella isolates. The Foodborne Diseases Active Surveillance Network (FoodNet) ascertains outcomes for patients with culture-confirmed Salmonella infection, in 9 states, each of which participates in NARMS. We analyzed the frequency of bloodstream infection and hospitalization among patients with resistant infections. Isolates defined as resistant to a clinically important agent were resistant to 1 or more of the following agents: ampicillin, ceftriaxone, ciprofloxacin, gentamicin, and/or trimethoprim-sulfamethoxazole. RESULTS During 1996-2001, NARMS received 7370 serotyped, nontyphoidal Salmonella isolates from blood or stool. Bloodstream infection occurred more frequently among patients infected with an isolate resistant to > or =1 clinically important agent (adjusted odds ratio [OR], 1.6; 95% confidence interval [CI], 1.2-2.1), compared with patients with pansusceptible infection. During 1996-2001, FoodNet staff ascertained outcomes for 1415 patients who had isolates tested in NARMS. Hospitalization with bloodstream infection occurred more frequently among patients infected with an isolate resistant to > or =1 clinically important agent (adjusted OR, 3.1; 95% CI, 1.4-6.6), compared with patients with pansusceptible infection. CONCLUSIONS Patients with antimicrobial-resistant nontyphoidal Salmonella infection were more likely to have bloodstream infection and to be hospitalized than were patients with pansusceptible infection. Mitigation of antimicrobial resistance in Salmonella will likely benefit human health.

Collaboration


Dive into the Frederick J. Angulo's collaboration.

Top Co-Authors

Avatar

Martyn Kirk

Australian National University

View shared research outputs
Top Co-Authors

Avatar

Duc J. Vugia

California Department of Public Health

View shared research outputs
Top Co-Authors

Avatar

Timothy J. Barrett

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert V. Tauxe

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Niko Speybroeck

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert M. Hoekstra

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Beletshachew Shiferaw

Oregon Department of Human Services

View shared research outputs
Researchain Logo
Decentralizing Knowledge